Related Experiment Videos
The effect of caffeine on exercise-induced bronchoconstriction.
S Kivity1, Y Ben Aharon, A Man
1Institute of Pulmonary and Allergic Disease, Ichilov Hospital, Sackler School of Medicine, Tel-Aviv University, Israel.
Chest
|May 1, 1990
Summary
High doses of caffeine (7 mg/kg) can help prevent exercise-induced bronchoconstriction in asthma patients by improving FEV1. Lower doses were not effective, but caffeine was well tolerated.
Area of Science:
- Pulmonology
- Exercise Physiology
- Pharmacology
Background:
- Exercise-induced bronchoconstriction (EIB) is a common condition in asthma patients.
- Caffeine is a widely consumed stimulant with potential bronchodilator effects.
Purpose of the Study:
- To investigate the efficacy of caffeine in preventing exercise-induced bronchoconstriction (EIB) in patients with bronchial asthma.
- To determine the dose-response relationship of caffeine for preventing EIB.
Main Methods:
- Ten patients with bronchial asthma participated in a randomized, placebo-controlled study.
- Participants received placebo, caffeine 3.5 mg/kg, or caffeine 7 mg/kg two hours before exercise.
- Spirometry was performed at baseline, 1-2 hours post-ingestion, and post-exercise (5, 15, 30 minutes).
Main Results:
- Caffeine significantly improved baseline FEV1 at both tested doses.
- Only the higher dose of caffeine (7 mg/kg) significantly prevented exercise-induced bronchoconstriction.
- Caffeine was well tolerated by all participants at both doses.
Conclusions:
- High-dose caffeine (7 mg/kg) demonstrates a significant protective effect against exercise-induced bronchoconstriction in asthma.
- Caffeine may be a viable option for managing EIB in asthma patients, particularly at higher doses.
- Further research is warranted to confirm these findings and explore optimal dosing strategies.